Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials

BACKGROUND: In early breast cancer (BC) the impact of denosumab on survival outcomes is still unclear. We undertook a systematic review and meta-analysis to assess efficacy and safety of adjuvant denosumab in addition to standard anticancer therapy. METHODS: PubMed, CENTRAL, Scopus, Embase, and onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrantoni, Luca, Garufi, Giovanna, Di Monte, Elena, Maliziola, Noemi, Pasqualoni, Mariangela, Pontolillo, Letizia, Pannunzio, Sergio, Cannizzaro, Maria Chiara, Di Bello, Armando, Fabi, Alessandra, Palazzo, Antonella, Tortora, Giampaolo, Bria, Emilio, Orlandi, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240867/
https://www.ncbi.nlm.nih.gov/pubmed/37284523
http://dx.doi.org/10.1177/17588359231173180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240867/
https://www.ncbi.nlm.nih.gov/pubmed/37284523
http://dx.doi.org/10.1177/17588359231173180

Ejemplares similares